Treatment Registry
TR-0719 ActiveRecorded September 2026Last verified October 2026

Compounded semaglutide

Sold by ReflexMD · every compounded semaglutide record

The register has not established whether this program ships a vial, a pen, or another form. That is a gap in our record, not a statement about the company.

Price

TermPublished rateCharged today
Semaglutide advertised monthly program

Price conditions have not been established; the quoted figure is not a verified recurring rate.

Prescription approval required; initial invoice and any selected quarterly plan must be confirmed.

“Compounded $297/mo Semaglutide”

$297Published figureCharged todayNot verified
Price sources
Visit ReflexMD

We earn nothing from this link. It opens ReflexMD's website without a paid referral.

History

Fewer than two comparable calendar-month readings are available for a price trend. Day- or week-based supplies, introductory offers and unverified payment terms are not connected in this chart.

  • September 2026 — Entry added to the register

Sourcing and terms

PharmacyNot disclosed
StatesNot disclosed
PrescriberAsynchronous review
CancellationTerms require cancellation at least two days before renewal processing. Paid monthly fees are generally nonrefundable and access continues through the paid period. Terms and fulfillment pages specify phone cancellation for non-California residents and phone or email for California; the help center separately describes phone or email without that state restriction. The eligibility FAQ promises a full refund when a prescriber determines GLP-1 treatment is inappropriate. Confirm the applicable cancellation channel and billing interval, including any quarterly plan, before paying. https://www.reflexmd.com/pages/fulfillment
MembershipRequired, included in program price. Amount not published. The Program Membership Fee includes medication and pharmacy fulfillment; do not add it to the program price.
Consult feeIncluded in program price; itemized amount is not published. The public consultation FAQ states that the fee is included in the subscription; the inclusion FAQ lists virtual consultation, medication and shipping.

Recorded from reflexmd.com. Unlike the price rows above, these carry a summary rather than a word-for-word quotation, so they are not shown in quotation marks.

Notes

  1. 1. September 2026 — The rendered homepage's VISIBLE TEXT shows $297/mo Semaglutide and $367/mo Tirzepatide, but the DOM also contains a second, non-visible price block quoting $299/mo Semaglutide and $399/mo Tirzepatide (likely an A/B variant or stale slide) -- only the visible figures are reported here. The Terms page states the ReflexMD Program Membership Fee 'includes the cost of medication,' so this is a real program price, not a medication-excluding membership fee. A separate '3-in-1 Weight Control Pills' product at $199/mo ($7/day) is advertised alongside 'GLP-1s' as a distinct, non-GLP-1 category ('3-month plans of GLP-1s or Weight Control Pills' and a 'View GLP-1 Injections' link from the pill page) so it was excluded as out of scope. No vial/pen form or served-states list is disclosed anywhere checked.
  2. 2. October 2026 — Public terms say membership includes medication and pharmacy fulfillment; membership is not an extra charge on top of the advertised program. Terms allow monthly or quarterly periods, whereas the fulfillment page describes month-to-month service. No named dispensing pharmacy, affirmative program coverage list is established in these policy pages. https://www.reflexmd.com/pages/terms
  3. 3. October 2026 — The current rendered homepage displays compounded semaglutide at $297 per month. This is an advertised monthly program price; no initial invoice or quarterly payment is verified. A separate new-customer offer advertises 15% off three-month plans, without establishing a payable total here. The homepage describes clinician review of submitted medical answers, followed by a prescription if appropriate. Consultation, medication and shipping are included according to the public FAQ. https://www.reflexmd.com/ https://help.reflexmd.com/hc/en-us/articles/19351524889876-What-is-included-in-the-subscription-fee
  4. 4. October 2026 — The current homepage also advertises an oral weight-control product without identifying a GLP-1 ingredient. Educational articles about Ozempic or Wegovy do not establish additional active branded offers. No additional GLP-1 program identity is created from those mentions. Self-injection instructions do not identify the actual device or establish a separate branded product. https://www.reflexmd.com/pages/instructions

1 further note concerns other ReflexMD programs and sit on the provider record.

Treatment Registry is an independent editorial record. It is not a government registry, a licensing body, or a certification. An entry means we recorded what a company published on a given date. It does not mean we recommend the program, and it does not mean the program is approved by anyone.

This record

Entry
TR-0719
Medication category
compounded semaglutide
Readings
2

Related records

Cite this entry

Treatment Registry. (2026). ReflexMD — compounded semaglutide (TR-0719). Last verified October 2026. Retrieved [your access date], from https://treatmentregistry.com/registry/TR-0719

Replace the bracket with the date you read it. Ours is the date we last checked the figures, which is a different thing and is given separately.